Advertisement

NLA Recommendations for Patient-Centered Management of Dyslipidemia

Last Updated:
Publish Date: 
May 17, 2017 - 2:00pm

NLA Recommendations for Patient-Centered
Management of Dyslipidemia

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report

Terry A. Jacobson, MD, Matthew K. Ito, PharmD, Kevin C. Maki, PhD, Carl E. Orringer, MD, Harold E. Bays, MD, Peter H. Jones, MD, James M. McKenney, PharmD, Scott M. Grundy, MD, PhD, Edward A. Gill, MD, Robert A. Wild, MD, PhD, Don P. Wilson, MD, W. Virgil Brown, MD

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

Terry A. Jacobson, MD, Kevin C. Maki, PhD, Carl E. Orringer, MD, Peter H. Jones, MD, Penny Kris-Etherton, PhD, Geeta Sikand, MA, Ralph La Forge, MSc, Stephen R. Daniels, MD, PhD, Don P. Wilson, MD, Pamela B. Morris, MD, Robert A. Wild, MD, PhD, MPH, Scott M. Grundy, MD, PhD, Martha Daviglus, MD, PhD, Keith C. Ferdinand, MD, Krishnaswami Vijayaraghavan, MD, Prakash C. Deedwania, MD, Judith A. Aberg, MD, Katherine P. Liao, MD, MPH, James M. McKenney, PharmD, Joyce L. Ross, MSN, CRNP, Lynne T. Braun, PhD, CNP, Matthew K. Ito, PharmD, Harold E. Bays, MD, W. Virgil Brown, MD On behalf of the NLA Expert Panel

National Lipid Association Updated Recommendations on the Use of PCSK9 Inhibitors

Carl E. Orringer, MD, Terry A. Jacobson, MD, Joseph J. Saseen, PharmD, Alan S. Brown, MD, Antonio M. Gotto, MD, Joyce L. Ross MSN, CRNP, James A. Underberg, MD

Resources

Education

Media

Additional Publications

Click here to view additional NLA publications

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service